Intron Health
Healthcare Research & Advisory
A New Street Research Company
Slider

Identifying New Investment Opportunities in an Increasingly Complex Landscape

As Global Pharmaceutical output continues to soar driven by new technologies drawn from the broader Healthcare space, we believe there is the need for a dedicated European Healthcare Boutique to help investors identify new opportunities and piece together the increasingly complex landscape.

We have written extensively, highlighting that the sector is entering an R&D SuperCycle which will last well into the next decade. We aim to help investors benefit from this trend by identifying companies with structural growth that will ride high on this extended innovation wave.

Thought Leadership

Intron Health aims to be investors’ Healthcare partner of choice with high quality, thought leadership.

Global Coverage

Our ever-expanding global coverage finds investment opportunities with structural growth that benefit from the R&D SuperCycle.

Extensive Experience

Founded by Naresh Chouhan and Dominic Rose in 2016, the team has almost 100 years of combined experience.

We’ve Entered an R&D SuperCycle

Aggregate Forecasted Future Peak Sales of Drugs Approved

Big Pharma Phase 3 Success Rates by Year

Intron Health is a Trading name and Equity Partner of New Street Research LLP. Intron Health is Regulated by the FCA under New Street Research LLP. Click here for the New Street Research Website.